Prosecution Insights
Last updated: April 19, 2026

Cellartgen Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18355798 DECELLULARIZED TISSUE-DERIVED EXTRACELLULAR MATRIX FUNCTIONALIZED WITH PHENOL DERIVATIVE AND USE THEREOF THUESON, HANNA MARIE 1638 Non-Final OA Jul 20, 2023
18324601 TISSUE GELL FOR TRANSPLANTATION USING DECELLULARIZED EXTRACELLULAR MATRIX AND METHOD OF PREPARING THE SAME SCHUBERG, LAURA J 1631 Non-Final OA May 26, 2023
18253047 PANCREAS EXTRACELLULAR MATRIX DERIVED SCAFFOLD FOR CULTURE AND TRANSPLANTATION OF PANCREATIC ORGANOID AND METHOD OF PREPARING THE SAME BEHARRY, ZANNA MARIA 1632 Non-Final OA May 16, 2023
18252895 KIDNEY EXTRACELLULAR MATRIX-DERIVED SCAFFOLD FOR CULTURE AND TRANSPLANTATION OF KIDNEY ORGANOID AND METHOD OF PREPARING THE SAME AMICK, THOMAS RUSSE 1638 Non-Final OA May 15, 2023
18176890 BIO-INSPIRED TISSUE-ADHESIVE HYDROGEL PATCH FOR PREVENTING OR TREATING CARTILAGE OR BONE DISEASE WORSHAM, JESSICA N 1615 Final Rejection Mar 01, 2023

Managing Cellartgen Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month